Developing High Affinity Peptides to Target SARS-CoV-2 Spike (S) Protein

Investigators: Richard Roberts; Terry Takahashi

First Small Molecular for Retinal Degenerations

Investigators: Stan Louie; Mark Humayun

Engineering natural killer cells to target HLA-DR-negative hematologic malignancies

Investigators: Jianming Xie; Alan Wayne

Targeting CD99 and FLT3 to eliminate leukemia stem cells (LSCs) in Acute Myeloid Leukemia

Investigators: Houda Alachkar; Andrew Mackay; George Yaghmour

Novel Dynamic PET Kinetics and MRI Radiomics Analyses in Brain Tumors

Investigators: Hossein Jadvar; Andrew MacKay; Krishna Nayak;

DSCR1, anti-angiogenesis drug target against solid tumors with focus on colorectal cancer

Investigators: Heinz-Josef Lenz; Fariborz Nasertorabi

Novel Deep Learning Techniques for Imputing Medical Images: Application in Clinical Management of Renal Masses

Investigators: Assad Oberai; Vinay Duddalwar; Inderbir Gill

Determining Predictors of Response to Oncolytic Virus Immune Priming

Investigators: Kevin Kelly; Peter Kuhn; Wendy Cozen

Establishing a Diagnosis of Lung Cancer Through a Fluid Biopsy

Investigators: Peter Kuhn; Jorge Nieva

The Development of huLym-1DAPCAR-T Cells for B-cell Lymphoma Therapy

Investigators: Alan Epstein; Stan Louie